Grateful for receiving the first Sjaastad Prize in the field of #headache! Honored to be picked by the Norwegian headache society and thankful for bein a part of the 2024 National Headache conference by @NorHeadResearch

Clinicians should be aware that sub/epidural injection of contrast can potentially cause CSF-venous fistula and that transvenous embolization has emerged as a minimally invasive therapy to treat this disease: https://t.co/WaY69esUWb #NeuroTwitter #NeuroX

This study examined the potential association between GLP-1RA use and the development of diabetic lumbosacral radiculoplexus neuropathy and common fibular neuropathy, both of which have been linked to weight loss: https://t.co/GGref5SjME #NeuroTwitter #NeuroX

Most viewed this week from @JAMANeuro: GLP-1 RA therapy may offer an alternative management strategy for idiopathic intracranial hypertension. https://t.co/vtNT21KOMt

GLP-1 drugs may provide benefit for idiopathic intracranial hypertension https://t.co/HR4MTFPRjo https://t.co/Z8dSURBmsO

The ongoing need for #migraine treatments calls for deeper insight into their underlying biology. Dr. Peter Goadsy reviews the role of #glutamate, a critical neurotransmitter and brain chemical that could be a target for treatment. https://t.co/4mXyHUmuhc

@JCephalalgia Editor's Choice Article @Simona_Sacco_ - Video Program. Congratulations @MyklandMartin Dr Omland on the great publication & interview #Migraine #Sleep! @NinaRiggins https://t.co/fiNcIqjbPY

@NTNU @NTNUhelse @NinaRiggins @JCephalalgia

Recent study from @PetterOmland on the impact of insufficient sleep on #migraines. Results show altered pain responses in migraine sufferers compared to controls after reduced sleep. Findings highlight a vulnerability to insufficient sleep between attacks.

Does insufficient sleep and the ictal phase have similar effects on homeostatic inhibitory effects in migraine? https://t.co/eMnwabXniX @NTNU @NTNUhelse @NinaRiggins

Thanking @ihs_official @Simona_Sacco_ for highlighting our latest findings in #migraine. We found similar changes in nociceptive habituation after insufficient sleep as is previously observed in the ictal phase of migraine. https://t.co/laFTOay40t @PetterOmland @NorHeadResearch

MR imaging may detect signs of intracranial hypotension • No marked increase of the Bern score was observed in either healthy controls or patients with persistent Post-traumatic headache (PTH). • Spontaneous intracranial hypotension (SIH) should be thoroughly investigated in

A multidisciplinary headache team effectively reduces headache frequency, sick leave, and psychological distress in patients with present or recurrent headache-related sick leave. https://t.co/fiPqPi6uKz #migraine #headache #brain #pain #neurology #neuroscience

Pleased to share the release of the new Migraine Guideline! A joint effort by the @SISCCefalee and @ihs_official Two versions are available on @JCephalalgia : • Summary version: https://t.co/kTUXlYkPNy • Extended version:

Preventive treatment with anti-CGRP mAbs and BTX-A effectively reduces non-perimenstrual headache and non-perimenstrual migraine days but appears to have limited efficacy in perimenstrual headache and migraine days. • The perimenstrual window represents the period with the

March's Editor's Choice @Simona_Sacco_ We are pleased to announce and congratulate the authors on their paper, “Migraine and insufficient sleep: The effect of sleep restriction on nociceptive evoked potentials in migraine” which has been selected as the Editor’s Choice for the

This study found that insufficient sleep may increase cortical inhibitory responses to nociceptive stimulation in migraine. This finding supports the idea that migraine is associated with a vulnerability for insufficient sleep. https://t.co/ZXI5WFQnb6 #migraine #headache #brain

A wearable, battery-powered rTMS device has been engineered. Weighing under 7lbs and consumes 90% less energy than typical TMS systems, this device enables brain stimulation to be done anywhere.

🧠 March 16th - 22nd, 2025, marks International Headache Week, a time to raise awareness about the burden of headache disorders and advocate for better care and research. Furthermore, March 21st, 2025, is Cluster Headache Awareness Day, dedicated to highlighting one of the most

Annoucment of the Jes Olesen Awards. The International Headache Society (IHS) has announced the launch of the annual Jes Olesen Awards. Two awards will be granted each year, recognising outstanding original contributions in each of clinical and basic science research. Read the

🚨 Position Statement Alert 🚨 Migraine prevention needs a paradigm shift! This paper from @ihs_official advocates for raising treatment goals beyond the traditional ≥50% reduction in migraine days, emphasizing absolute outcomes like migraine freedom or minimal residual burden.